Brief: BB Biotech Q1 Net Profit At CHF 260 Mln
April 26 (Reuters) - BB BIOTECH AG BION.S :
* PRESENTS SOLID FIRST-QUARTER RESULTS; BIOTECH STOCK MARKET
IMPACTED BY SHIFTING VIEWS ON INTEREST RATES
* NET PROFIT FOR Q1 OF 2024 AMOUNTED TO CHF 260 MN (NET LOSS
OF
CHF 254 MN IN PRIOR-YEAR QUARTER)
* SIGNIFICANT NEWS FLOW IS EXPECTED OVER COURSE OF YEAR
Source text for Eikon: ID:nEQ4Vp1Vva
Further company coverage: BION.S
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Bb Biotech AG
See all newsBrief: BB Biotech Reports Net Profit Of CHF 451 Mln In Q2 2026
Switzerland's BB Biotech Q1 net loss narrows amid portfolio rotation
Brief: BB Biotech Reports Q1 Net Loss Of CHF 21 Million
Brief: BB BIOTECH Q1 Net Income CHF -21 Million
Brief: BB Biotech Says All Proposals Of Board Of Directors Approved At AGM